Navigating the Therapeutic Pathway and Optimal First-Line Systemic Therapy for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
Research output: Contribution to journal › Review article › peer-review
5
Citations
(Scopus)